More than 800 million adults worldwide are living with diabetes, according to a new study in the journal The Lancet.

However, depression goes undiagnosed in 50%-75% of patients with chronic conditions such as diabetes mellitus. Additionally, there is limited information about the prevalence of depression among ...

The AMA’s What Doctors Wish Patients Knew™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines. In this installment, Edward Esparza, ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

These changes allowed Medicare Advantage plans to improve care at lower costs for certain critical services, such as when diabetic patients visit endocrinologists or need more frequent foot exams.

Wright and other advocates for diabetes patients who need insulin to survive worry the nation's supply has become unreliable. Certain brands of insulin have been in shortage multiple times since ...

In view of the evidence suggesting that insulin resistance and inflammation have a contributing role in the elevated risk for depression in people with type 2 diabetes, the authors expected patients ...

An oral formulation of semaglutide, taken daily, is more effective at reducing the risk of major adverse cardiovascular events than traditional therapy alone in patients with diabetes and established ...

The semaglutide injectables, Ozempic and Wegovy, have been the centre of attention since they launched due to their stronger metabolic effects both on T2D and obesity patients ... is currently ...

And the number of patients scrambling could grow soon to nearly 40,000 because Point32Health, the state’s second-largest insurer, is also at an impasse with a third health system, Tenet ...

As many as 3.2 million people in the UK are prediabetic according to Diabetes UK; that is, they are at risk of developing Type 2 diabetes (T2D) due to higher than normal blood glucose levels.

and was tested in the trial on diabetic patients who also suffered from established cardiovascular disease and/or chronic kidney disease.